Treatment of Diabetic Macular Edema with Aflibercept in Eyes with Previous Nonresponse to Ranibizumab and/or Bevacizumab

被引：0
|
作者：
Sadowsky, Rachel [1 ]
Quiram, Polly [2 ]
机构：
[1] Univ Minnesota, Minnetonka, MN USA
[2] VitreoRetinal Surg, PA, Minneapolis, MN USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2016年 / 57卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
2104
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
    Wells, John A.
    Glassman, Adam R.
    Ayala, Allison R.
    Jampol, Lee M.
    Aiello, Lloyd Paul
    Antoszyk, Andrew N.
    Arnold-Bush, Bambi
    Baker, Carl W.
    Bressler, Neil M.
    Browning, David J.
    Elman, Michael J.
    Ferris, Frederick L.
    Friedman, Scott M.
    Melia, Michele
    Pieramici, Dante J.
    Sun, Jennifer K.
    Beck, Roy W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (13): : 1193 - 1203
  • [2] Aflibercept therapy for diabetic macular edema resistant to ranibizumab and bevacizumab
    Karth, Peter
    Moshfeghi, Darius M.
    Leng, Theodore
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [3] Conversion to aflibercept for diabetic macular edema unresponsive to ranibizumab or bevacizumab
    Lim, Laurence S.
    Ng, Wei Yan
    Mathur, Ranjana
    Wong, Doric
    Wong, Edmund Y. M.
    Yeo, Ian
    Cheung, Chui Ming Gemmy
    Lee, Shu Yen
    Wong, Tien Yin
    Papakostas, Thanos D.
    Kim, Leo A.
    CLINICAL OPHTHALMOLOGY, 2015, 9 : 1715 - 1718
  • [4] Aflibercept for Diabetic Macular Edema in Eyes Previously Treated With Ranibizumab and/or Bevacizumab May Further Improve Macular Thickness
    Shah, Chirag P.
    Heier, Jeffrey S.
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2016, 47 (09): : 836 - 839
  • [5] Comparative Effectiveness Trial of Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
    Sun, Jennifer K.
    DIABETES, 2015, 64 : A76 - A77
  • [6] Comparisons of Efficacy of Intravitreal Aflibercept and Ranibizumab in Eyes with Diabetic Macular Edema
    Shimizu, Norihiro
    Oshitari, Toshiyuki
    Tatsumi, Tomoaki
    Takatsuna, Yoko
    Arai, Miyuki
    Sato, Eiju
    Baba, Takayuki
    Yamamoto, Shuichi
    BIOMED RESEARCH INTERNATIONAL, 2017, 2017
  • [7] Comparison of efficacy of intravitreal ranibizumab and aflibercept in eyes with diabetic macular edema
    Oshitari, T.
    Shimizu, N.
    Tatsumi, T.
    Takatsuna, Y.
    Arai, M.
    Sato, E.
    Yamamoto, S.
    ACTA OPHTHALMOLOGICA, 2016, 94
  • [8] Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema Extrapolation of Data to Clinical Practice
    Heier, Jeffrey S.
    Bressler, Neil M.
    Avery, Robert L.
    Bakri, Sophie J.
    Boyer, David S.
    Brown, David M.
    Dugel, Pravin U.
    Freund, K. Bailey
    Glassman, Adam R.
    Kim, Judy E.
    Martin, Daniel F.
    Pollack, John S.
    Regillo, Carl D.
    Rosenfeld, Philip J.
    Schachat, Andrew P.
    Wells, John A., III
    JAMA OPHTHALMOLOGY, 2016, 134 (01) : 95 - 99
  • [9] Letter to the Editor: Aflibercept For Diabetic Macular Edema in Eyes Previously Treated With Ranibizumab And/Or Bevacizumab May Further Improve Macular Thickness
    Calugaru, Dan
    Calugaru, Mihai
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2017, 48 (07): : 528 - 529
  • [10] Aflibercept in diabetic macular edema refractory to previous bevacizumab: outcomes and predictors of success
    Laiginhas, Rita
    Silva, Marta Ines
    Rosas, Vitor
    Penas, Susana
    Fernandes, Vitor Adriano
    Rocha-Sousa, Amandio
    Carneiro, Angela
    Falcao-Reis, Fernando
    Falcao, Manuel Sousa
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2018, 256 (01) : 83 - 89
12345